Petousis, Stylianos
Hamilos, Michalis
Pagonidis, Konstantinos
Vardas, Panos
Lazopoulos, Georgios
Anastasiou, Ioannis
Zacharis, Evangelos
Kochiadakis, George
Skalidis, Emmanouil
Article History
Received: 15 March 2022
Accepted: 13 June 2022
First Online: 2 July 2022
Declarations
:
: Our study had been approved by the Institutional Review Board of the University Hospital of Heraklion and was conducted in accordance to the declaration of Helsinki. Written informed consent was obtained from all subjects.
: Not applicable.
: Stylianos Petousis reports grants from the Hellenic Cardiovascular Research Society. Michalis Hamilos reports grants and personal fees from the Hellenic Cardiovascular Research Society, and personal fees from AstraZeneca and Sanofi. Panos Vardas reports personal fees from Menarini International, Dean Medicus, Servier, the European Society of Cardiology and Hygeia Hospitals Group. Ioannis Anastasiou reports non-financial support from the Hellenic Cardiovascular Research Society. Evangelos Zacharis reports non-financial support from the Hellenic Cardiovascular Research Society, and personal fees from Sanofi and Amgen. George Kochiadakis reports non-financial support from the Hellenic Cardiovascular Research Society, personal fees from AstraZeneca and Sanofi, and grants from Innovis, Servier and Abbott. Emmanouil Skalidis reports grants from the Hellenic Cardiovascular Research Society, and personal fees from AstraZeneca, Medtronic, Boehringer-Ingelheim and Pfizer.